What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders? / A. Wallin, S. Alladi, S.E. Black, C. Chen, S.M. Greenberg, D. Gustafson, J.D. Isaacs, H. Jokinen, R. Kalaria, V. Mok, L. Pantoni, F. Pasquier, G.C. Roman, G.A. Rosenberg, R. Schmidt, E.E. Smith, A.H. Hainsworth. - In: CEREBRAL CIRCULATION, COGNITION AND BEHAVIOR. - ISSN 2666-2450. - 3:(2022), pp. 100044.1-100044.3. [10.1016/j.cccb.2022.100044]
What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?
L. Pantoni;
2022
File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Aducanumab_CCCB editorial_FINAL.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
344.43 kB
Formato
Adobe PDF
|
344.43 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.